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Abstract 
Novel oxathiane spiroketal donors have been synthesised and activated via an umpolung S-
arylation strategy using 1,3,5-trimethoxybenzene and 1,3-dimethoxybenzene.  The 
comparative reactivity of the resulting 2,4,6-trimethoxyphenyl (TMP)- and 2,4-
dimethoxyphenyl (DMP)-oxathiane spiroketal sulfonium ions is discussed, and their α-
stereoselectivity in glycosylation reactions are compared to the analogous TMP- and DMP- 
sulfonium ions derived from a oxathiane glycosyl donors bearing a methyl ketal group. The 
results show that the stereoselectivity of the oxathiane glycosyl donors is dependent on the 
structure of the ketal group and reactivity can be tuned by varying the substituent on the 
sulfonium ion.  
 
1. Introduction 
The chemical synthesis of complex oligosaccharides presents many technical challenges 
ranging from lengthy reaction sequences through to problematic purification steps.1,2 But 
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such is the biological importance of carbohydrates3 that solutions for many of these 
difficulties are on the horizon, for example through ‘one-pot’ glycosylations using 
orthogonally activated donors4-6 and the advent of solid phase automated oligosaccharide 
synthesis.1,7-10 Despite these advances, however, stereocontrol over the formation of the 
glycosidic linkage still remains a challenge, particularly in the synthesis of 1,2-cis 
glycosides.11-15 Much recent work in this field has focussed on the study of stabilised 
glycosyl sulfonium ions and their stereodirecting ability,16-22 including our recent report of 
oxathiane ketal-S-oxide glycosyl donors 1 for stereoselective 1,2-cis glycosylations (Scheme 
1a).19   
 
Scheme 1 a) Umpolung S-arylation strategy for oxathiane ketal-S-oxide donors 1.  b) 
Oxathiane ketal donor scaffold 4 and oxathiane spiroketal donor scaffold 6.   
 Attempts to arylate glycosyl oxathianes with benzyne led to the formation of  glycosyl 
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acetates.21 However, oxidation of the oxathiane to give oxathiane ketal-S-oxides 1, and 
subsequent treatment with Tf2O, led to the formation of surprisingly stable activated 
intermediates which were sufficiently long-lived to undergo electrophilic aromatic 
substitution in the presence 1,3,5-trimethoxybenzene (TMB). Therefore, conversion of the 
previously nucleophilic sulfide into an electrophilic S(IV) centre facilitated an “umpolung” 
approach to S-arylation. The resulting 2,4,6-trimethoxyphenyl (TMP)-oxathiane ketal 
sulfonium ions 2 then afforded α-glycosides 3 with complete stereoselectivity following 
heating at 50 °C.  However, although glycosylation reactions with oxathiane ketal sulfonium 
ions 4 are notable for the formation of glycosides with complete α-stereoselectivity,19,21 the 
resulting O-2 acyclic ketal formed in the product 5 occasionally decomposed under the 
reaction conditions, diminishing yields in more challenging glycosylation reactions.  
Therefore, in an attempt to circumvent this issue, we set out to design a new oxathiane donor 
scaffold in which the axial methoxy group was replaced with an O-substituent constrained in 
a spirocyclic ring (Scheme 1b).  It was anticipated that following glycosylation, spiroketal 
sulfonium ion 6 would afford glycosides 7 bearing an O-2 cyclic ketal which would be more 
stable than the corresponding O-2 acyclic ketal, but still sufficiently labile to be removed by 
Lewis acid catalysed cleavage.  To this end, we present the synthesis and activation of 
oxathiane spiroketal-S-oxides via an umpolung S-arylation strategy, and compare their α-
stereoselectivities in glycosylation reactions with the analogous oxathiane ketal sulfonium 
ions.  We also demonstrate that the stability and α-stereoselectivity of oxathiane spiroketal 
sulfonium ions in glycosylation reactions can be modulated by changing the S-aryl appendage 
exogenous to the oxathiane ring.  Both TMP and 2,4-dimethoxyphenyl (DMP) sulfonium ions 
are synthesised and their reactivity and α-stereoselectivities compared. 
 
2. Results and Discussion 
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The synthesis of the oxathiane spiroketal donor began from pentaacetate 8, which was 
activated with a Lewis acid in the presence of thiourea to afford an intermediate β-glycosyl 
isothiouronium salt.23,24 Thioglycoside 9 was then isolated in 50% yield following treatment 
with Et3N and mesylated dihydropyran 17, which was synthesised from alcohol 16 (Scheme 
2).25  Subsequent deacetylation under Zemplén conditions afforded the unprotected 
thioglycoside, which was subjected to a regio- and stereoselective acid catalysed cyclisation 
to afford key oxathiane spiroketal scaffold 10 in 60% yield over two-steps.  Acetylation then 
furnished protected spiroketal 11, which was oxidised with m-CPBA to afford sulfoxide 13 in 
93% yield with a diastereomeric ratio of 93:7. The equatorial sulfoxide 13-R was 
unequivocally assigned as the major diastereomer based on analysis of the geminal coupling 
constants for the methylene protons adjacent to sulfur.26,27 Benzylation of triol 10 similarly 
led to the protected oxathiane 12 which was oxidised to sulfoxide 14 as virtually a single 
diastereomer in 30% yield over two-steps.  Importantly the structural integrity of the 
spiroketal ring was confirmed by x-ray crystallographic analysis.  The x-ray structure of the 
acetylated axial sulfoxide 13-S (Scheme 2) illustrates how the interlocked ring configuration 
benefits from stabilisation by double n(O)→σ*(C-O) overlap.28-30 
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Scheme 2 Reagents: (a) (i) BF3·OEt2/SC(NH2)2/CH3CN (ii) Et3N/17 (50%); (b) (i) 
NaOMe/MeOH (ii) p-TSA/CHCl3 (60%); (c) 11 Ac2O/Et3N/DMAP/CH2Cl2 (100%); 12 
NaH/BnBr/DMF; (d) 13 m-CPBA/CH2Cl2 (93%, d.r. 97:3, only the major diastereomer is 
shown); 14 m-CPBA/CH2Cl2 (30% from 10, d.r. 99:1); (e) n-BuLi/TMEDA/THF/(CH2O)n 
(47%); (f) Et3N/MsCl/CH2Cl2 – the crude product 17 was used without purification. The 
crystal structure depicts an ellipsoid probability of 50%. 
   
 With spiroketal-S-oxide 13-R in hand, umpolung S-arylation using triflic anhydride and 
TMB was attempted (Figure 1). Pleasingly, clean formation of the TMP-sulfonium ion 18 as 
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a single diastereomer was observed by 1H NMR.  Assignment of sulfonium ion 
stereochemistry is tentative in the absence of both diastereomers of sulfonium ion 18, 
however, comparison of the geminal coupling constant for the methylene protons adjacent to 
sulfur are consistent with analogous equatorial aryl sulfonium salts.19  Following activation of 
sulfoxide 13-R, in CD2Cl2, a characteristic ~1.5 ppm downfield shift of the H-1 proton signal 
occurs,16,19 indicative of the formation of sulfonium ion 18. This is accompanied by similar 
downfield shifts for the H-axial and H-equatorial protons adjacent to the positively charged 
sulfur, and the appearance of signals corresponding to the aromatic protons and methoxy 
groups associated with the TMP S-appendage. 
 
Figure 1 Formation of TMP-spiroketal 18, observed by 1H NMR in CD2Cl2. 
 
Content that the formation of TMP-spiroketal 18 occurred under the reaction conditions, 
glycosylation of diacetone galactose 19 was then attempted.  As anticipated glycosylation 
reactions at room temperature proceeded very slowly, demonstrating the stability of 
sulfonium ion 18.  Therefore, the glycosylation reaction was attempted at an elevated 
temperature of 50 °C (Scheme 3). It proved convenient to cleave the O-2 cyclic ketal 
protecting group with BF3·OEt2 prior to isolation of glycoside product 20 which was obtained 
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in a yield of 38% over two-step (α:β 93:7).  By reducing the temperature to 37 °C, it proved 
possible to increase the yield of the glycosylation reaction, affording glycoside 20 in an 
improved yield of 60%, but without change to the anomeric ratio (α:β 93:7; Table 1, entry 1).   
 
 
Scheme 3 Reagents: (a) (i) Tf2O/TMB/DIPEA/−30 °C →−10 °C (ii) 19 /C2H4Cl2/−10 °C 
→50 °C (ii) BF3·OEt2/CH2Cl2. 
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Table 1 Glycosylation reactions with a) oxathiane spiroketal sulfonium ions 21 and 22 and b) 
oxathiane ketal sulfonium ions 23 and 24. 
 
 
Entry Donor  ArH ROH  Product Yield (%)a α:β 
1b 13-R TMB 19 20 60 93:7 
2b 13-R TMB iPrOH 28 61 98:2 
3c 14-R TMB 19 27 58 92:8d 
4c 14-R TMB iPrOH 29 57 96:4d 
5b 13-R DMB 19 20 50 86:14 
6b 13-R DMB iPrOH 28 52 95:5 
7e 25-R TMB 19f 20 85 >98:2g 
8e 26-R TMB iPrOHh 28 77 >98:2g 
9  25-R DMB 19f 20 62 >98:2g 
aIsolated yield over two-steps.  bGlycosylations were performed in CH2Cl2 at −30 °C, before 
being warmed to −10 °C, followed by ROH (1.5 equiv.) addition and stirring for 24 h at 37 
°C.  cAfter ROH (1.5 equiv.) addition reaction mixture was stirred for 24 h at RT.  dMeasured 
by 1H NMR, following purification on Sephadex LH-20 column.  eReproduced from 
reference 19 for comparison.   f2.5 equiv ROH.  gNo β-anomer was detected in 1H NMR of 
crude mixture.  h5 equiv ROH. 
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  These conditions were then applied to the glycosylation of secondary alcohol 
isopropanol with acetylated spiroketal 13-R, which afforded α-glycoside 28 in 61% yield, on 
this occasion with an improved anomeric ratio of α:β 98:2 (Table 1, entry 2). Glycosylation 
reactions with the benzylated spiroketal 14-R proceeded at room temperature, which is 
consistent with the increased reactivity that is expected on moving from the ‘disarming’ 
acetyl to the ‘arming’ benzyl ether protecting group.31,32 Thus, glycosylation of primary 
alcohol 19 afforded α-glycoside 27 in 58% yield with an α:β ratio of 92:8 (Table 1, entry 3), 
and glycosylation of isopropanol afforded the desired α-glycoside 29 in 57% yield and an α:β 
ratio of 96:4 (Table 1, entry 4).  Both reactions using the benzylated spiroketal 14-R were 
therefore marginally less α-stereoselective than the comparable glycosylations using the 
acetylated spiroketal 13-R; a trend noted previously with oxathiane ether glycosyl donors.21,33  
It was pleasing to note that glycosylation reactions using spiroketal donors required 
significantly less glycosyl acceptor than analogous reactions  Previously, it was found that the 
higher concentrations of acceptor were needed to avoid a competing glycosylation reaction 
involving MeOH that can be released from glycoside products bearing the methyl ketal 
protecting group on O-2.19  This side reaction was found to be equally problematic at either 
50 °C or room temperature. However, the increased stability of the O-2 cyclic ketal 
protecting group under the reaction conditions successfully avoids comparable side reactions. 
Although no quantitative comparison of the stability of the O-2 acyclic and cyclic ketal was 
performed, analysis of the crude reaction mixtures following glycosylation reactions using 
methyl ketal donors revealed significant loss of the O-2 acyclic ketal, while far less cleavage 
of the O-2 cyclic ketal was observed following reactions employing oxathiane spiroketal 
donors. The lower yields in reactions using spiroketal donors 13-R and 14-R, compared to the 
analogous reactions using the methyl ketal donors 25-R and 26-R (1.5 equiv. in entries 1-4 vs. 
2.5 equiv. in entry 7, or 5 equiv. in entry 8) may be a result of competing intramolecular 
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glycosylation.  However, no conclusive evidence for the formation of any resulting bicyclic-
O-glycoside products could be obtained, even prior to the Lewis acid catalysed cleavage step. 
  Although still highly α-stereoselective, the spiroketal sulfonium ions 21 were less 
stereoselective than the corresponding methyl ketal sulfonium ions 23.19  This difference is 
intriguing considering both sulfonium ions appear to have comparable reactivity and both 
scaffolds contain a ketal substituent in the oxathiane ring.  Recently, it has been proposed that 
the complete α-stereoselectivity of ketal sulfonium ions 23 may be a direct result of their 
inherent stability.33  This theory is based on the assumption that ketal 23 can exist in either its 
bicyclic sulfonium ion form, or in a ring opened oxacarbenium ion form.18,34-36 In a 
manifestation of the Thorpe-Ingold effect,37,38 the ketal group  is proposed to stabilise the 
cyclic sulfonium ion, thus promoting an ‘SN2-like’ α-stereoselective glycosylation.39-41 
However, from a comparison of the results reported in table 1, it seems unlikely that the α-
stereoselectivity of sulfonium ions 23 results simply from stabilising the oxathianium ion 
with a ketal group; instead it would appear that stereoselectivity may also be influenced by 
the other substituents on the oxathiane ring.   
  Therefore, our attention turned next to the S-aryl appendage on the sulfonium ions.  
2,6-Dimethoxyphenyl (DMP) sulfonium ions 22 and 24 were prepared to study the effects of 
removing a methoxy group from the aromatic ring.  Activation of the oxathiane ketal-S-oxide 
25-R in the presence of dimethoxybenzene (DMB) and addition of primary alcohol 19 
afforded the desired α-glycoside 20 in 62% yield (Table 1, entry 9).  The yield of the desired 
α-glycoside was lower than in the case of TMB activation (Table 1, entry 7), as a result of 
concomitant formation of the analogous α-methyl glycoside in 12% yield; nevertheless, both 
glycosides were still formed with complete α-stereoselectivity. However, when spiroketal-S-
oxide 13-R was activated in the same fashion, the resulting DMP-sulfonium ion afforded 
glycosides with lower α-stereoselectivity than observed for the TMP-sulfonium ion. For 
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example, glycosylation of primary alcohol 19 afforded the glycoside 20 in 50% yield with an 
anomeric ratio of α:β 86:14 (Table 1, entry 5), compared to α:β 93:7 for glycosylation using 
the analogous TMP-sulfonium ion (Table 1, entry 1).  Also glycosylation of isopropanol 
afforded α-glycoside 28 in 52% yield with an anomeric ratio of α:β 95:5 (Table 1 , entry 6), 
which was less α-stereoselective than the corresponding glycosylation using the TMP-
sulfonium ion (α:β 98:2, Table 1, entry 2).  
  We wondered if the reduction in α-stereoselectivity on moving from TMP sulfonium 
ions to DMP sulfonium ions would be accompanied by any differences in reactivity of the 
spiroketal sulfonium ions.  To this end, the reaction of MeOH with equimolar amounts of 
TMP sulfonium ion 18 and DMP sulfonium ion 30 was monitored by 1H-NMR spectroscopy 
in CD2Cl2 (Figure 2).   
 
Figure 2. 1H-NMR stackplot illustrating relative reactivities of TMP sulfonium ion 18 and 
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DMP sulfonium ion 30 in CD2Cl2 at room temperature. 
 
  After 35 h at RT, the H-1 signal of the TMP-spiroketal 18 was 48% of its original 
intensity (52% reacted), while the H-1 signal for the DMP-spiroketal 30 was only 24% of its 
original intensity (76% reacted). The reduction in H-1 signal intensities was also 
accompanied by the formation of methyl glycosides 31-TMP/DMP, characterised by an H-1 
doublet at ~4.8 ppm. The experiment demonstrated that DMP sulfonium ion 30 was 
approximately 1.5 times as reactive as the TMP sulfonium ion 18.  However, this experiment 
also illustrates the high stability of these spiroketal sulfonium ions as the glycosylation 
reaction was still not complete after 93 h at room temperature (4% DMP-spiroketal 30 and 
10% TMP-spiroketal 18 remained).  The increased reactivity of the DMP sulfonium ion 30 is 
perhaps unsurprising, as intuition would suggest that the more electron donating TMP 
aromatic group should stabilise the positively charged sulfonium ion more effectively.18,42 
This reactivity difference may also be reflected in the H-1 proton shifts for the sulfonium 
ions, as the more reactive and less stabilised DMP sulfonium ion 30 has the lowest field H-1 
signal at 5.9 ppm compared to the more shielded TMP sulfonium ion H-1 signal at 5.75 ppm.   
  Therefore, the decrease in the α-stereoselectivity of glycosylation reactions using the 
DMP sulfonium ion 30 compared to the TMP sulfonium ion 18 is accompanied by an 
increase in reactivity of the sulfonium ion. A similar trend was observed when increasing the 
reactivity of the sulfonium ions by moving from ester to benzyl ether protecting groups.33  
However, due to the limited scope of this study, care must be taken not to over interpret this 
correlation between reactivity and α-stereoselectivity.   
  In conclusion, the synthesis and reactivity of new oxathiane spiroketal glycosyl 
donors have been described.  The aryl sulfonium ions derived from the oxathiane spiroketal-
S-oxides 13-R and 14-R have comparable stability to analogous sulfonium ions derived from 
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other oxathiane ketal donors, but afford glycosides with lower α-stereoselectivities than those 
reported previously.19 Stereoselectivity could be improved by changing the protecting groups 
on the sugar ring (esters vs. benzyl ethers) or the S-aryl appendage (TMP-sulfonium ion vs. 
DMP-sulfonium ion). Although these changes in stereoselectivity appear to correlate with the 
stability of the sulfonium ions, the stabilising effect of an oxygen substituent on the 
oxathianium ring is not sufficient to explain the high α-stereoselectivity of the oxathiane ketal 
donors.19  The difference in reactivity between TMP and DMP sulfonium ions in the 
spiroketal series potentially offers a strategy for ‘arming’ or ‘disarming’ oxathiane glycosyl 
donors without changing protecting groups. 
 
3. Experimental 
3.1 General Methods: All solvents were dried prior to use, according to standard 
methods.43 Trifluoromethanesulfonic anhydride (Tf2O) was distilled under a N2(g) 
atmosphere. Boron trifluoride diethyl etherate (BF3·OEt2) was distilled over calcium hydride, 
and all other commercially available reagents were used as received. Where appropriate 
anhydrous quality material was purchased. All solvents used for flash chromatography were 
GPR grade, except hexane and EtOAc, when HPLC grade was used. All concentrations were 
performed in vacuo, unless otherwise stated. All reactions were performed in oven dried 
glassware under a N2(g) atmosphere, unless otherwise stated.  1H NMR spectra were recorded 
at 500 MHz on a Bruker Avance 500 instrument or at 300 MHz on a Bruker Avance 300 
instrument. 13C NMR spectra were recorded at 75 MHz on a Bruker Avance 300 instrument. 
Chemical shifts are given in parts per million downfield from tetramethylsilane. The 
following abbreviations are used in 1H NMR analysis: s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, dd = double doublet, dt = double triplet, td = triple doublet, ddd = 
double double doublet.  In 1H NMR and 13C-NMR of the oxathiane spiroketals, the spiroketal 
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ring is labelled “a” through to “e” starting from the position α to the axial oxygen and ending 
at the ketal carbon.  Electrospray (ES+) ionisation mass spectra were obtained on a Bruker 
HCT Ultra Ion Trap mass spectrometer connected to an Agilent 1200 series HPLC system, 
and high resolution ES+ were perfomed on a Bruker Daltonics MicroTOF mass spectrometer.  
Infra-red spectra were recorded on a Perkin-Elmer Spectrum One FT-IR spectrometer.  
Melting points were obtained on a Reichert hot-stage apparatus and are uncorrected.  Optical 
rotations were measured at the sodium D-line with an Optical Activity AA-1000 polarimeter. 
[α]D values are given in units of 10-1 deg cm2 g-1.  Analytical T.L.C was performed on silica 
gel 60-F254 (Merck) with detection by fluorescence and/or charring following immersion in a 
5% H2SO4/MeOH solution, unless otherwise stated. 
 
3.2 3,4-Dihydro-2H-pyran-6-(1-hydroxymethyl) (16)25 
Commercially available 3,4-dihydro-2H-pyran (15) (13.3 mL, 145.45 mmol) and TMEDA 
(24.1 mL, 160 mmol) were stirred and cooled to 0 °C.  nBuLi (100 mL, 160 mmol) was 
added slowly and the flask was cooled for a futher 45 min and then left for 20 h overnight at 
room temperature.  The colour of the solution changed from a pale yellow to a burnt orange 
with a precipitate.  Upon addition of tetrahydrofuran (100 mL) the precipitate dissolved to 
give an orange solution.  The reaction mixture was cooled to 0 °C and paraformaldehyde (9.6 
g, 320  mmol) was added portionwise (≈1 g per addition) over 1 h.  The reaction mixture was 
held at 0 °C for 1 h and left to warm to room temperature slowly, and then stirred for a 
further 20 h.  The reaction mixture was quenched with aq. NH4Cl (100 mL) and then diluted 
with Et2O (60 mL).  The organic phase was poured over a solution of CuSO4.5H2O (100 mL) 
and stirred for 30 min.  The ether was then decanted off and washed with saturated aq. 
NaHCO3 (2 x 100 mL), dried (MgSO4) and concentrated to afford 3,4-dihydro-2H-pyran-6-
(1-hydroxymethyl) (16) (7.85 g, 47%), as a yellow oil; RF 0.4 (1:1 (v/v) hexane-EtOAc); 1H 
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NMR: δH (500 MHz, C6D6); 4.59 (t, 1H, J 3.8 Hz, RC=CHCH2CH2CH2), 3.88 (s, 2H, 
CH2OH), 3.67 (t, 2H, J 5.1 Hz, RC=CHCH2CH2CH2), 1.71 (dd, 2H, J 6.4, J 4.0 Hz, 
RC=CHCH2CH2CH2), 1.38 (q, 2H, 6.0, J 5.1 Hz, RC=CHCH2CH2CH2); 13C-NMR: δC (75 
MHz, C6D6); 154.7 (RC=CHCH2CH2CH2), 97.1 (RC=CHCH2CH2CH2), 66.7 (CH2OH), 63.6 
(RC=CHCH2CH2CH2), 23.3 (RC=CHCH2CH2CH2), 20.8 (RC=CHCH2CH2CH2). 
 
3.3 (3,4-Dihydro-2H-pyranyl)-methyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-
glucopyranoside (9) 
Thiourea (1.35 g, 19.3 mmol) was added to a solution of 1,2,3,4,6-penta-O-acetyl-β-D-
glucopyranose (8) (6.83 g, 17.5 mmol) in MeCN (60 mL) and heated to 85 °C.  BF3·OEt2 
(4.66 mL, 36.8 mmol) was then added, and the reaction mixture was stirred for two hours at 
85 °C.  The solution was then cooled to room temperature and degassed before addition of 
Et3N (7.62 mL, 54.3 mmol).  Simultaneously, methanesulfonyl chloride (4.47 mL, 57.8 
mmol) was added to a separate solution of 3,4-dihydro-2H-pyran-6-(1-hydroxymethyl) (16) 
(6.0 g, 52.5 mmol) and Et3N (14.75 mL, 105 mmol) in CH2Cl2 (100 mL) at 0 °C before 
stirring for 10 min.  This solution was then added to the reaction mixture, which was left to 
stir at room temperature for 18 h.  The reaction mixture was then concentrated and 
redissolved in EtOAc (150 mL), washed with aq. NaCl (3 x 50 mL), dried and concentrated.  
The crude oil was purified by flash column chromatography (silica gel; 2:1 (v/v) hexane-
EtOAc) to afford (3,4-dihydro-2H-pyranyl)-methyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-
glucopyranoside (9) (4.0 g, 50% yield) as an orange oil; RF 0.19 (2:1 (v/v) hexane-EtOAc); 
[α]D21 18.9 (c 0.7, CHCl3); FTIR (vmax/cm-1) 1671 (C=C), 1750 (C=O); 1H NMR: δH (500 
MHz, CDCl3); 5.23 (t, 1H, J2,3 9.4 Hz, J3,4 9.4 Hz, H-3), 5.09 (dd, 1H, J1,2 10.3 Hz, J2,3 9.4 Hz, 
H-2), 5.04 (t, 1H, J3,4 9.4 Hz, J4,5 9.4 Hz, H-4), 4.69 (t, 1H, J 3.4 Hz, RC=CHCH2CH2CH2), 
4.63 (d, 1H, J1,2 10.3 Hz, H-1), 4.25 (dd, 1H, J5,6 5.1 Hz, J6,6' 11.9 Hz, H-6), 4.14 (dd, 1H, J5,6' 
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5.1 Hz, J6,6' 11.9 Hz, H-6'), 4.03 (m, 2H, RC=CHCH2CH2CH2), 3.67 (m, 1H, H-5), 3.33 (d, 
1H, J 13.6 Hz, SCH2), 3.13 (d, 1H, J 13.6 Hz, SCH2'), 2.08 (s, 3H, C(O)CH3), 2.05 (s, 3H, 
C(O)CH3), 2.02 (s, 3H, C(O)CH3), 2.01 (s, 3H, C(O)CH3), 2.07 (dd, 2H, J 3.4 Hz, J 5.1 Hz, 
RC=CHCH2CH2CH2), 1.82 (dd, 2H, J 5.1, J 6.0 Hz, RC=CHCH2CH2CH2); 13C NMR: δC (75 
MHz, CDCl3); 171.0, 170.7, 169.8 (C(O)CH3), 149.9 (RC=CHCH2CH2CH2), 99.7 
(RC=CHCH2CH2CH2), 82.8 (C-1), 76.1 (C-5), 74.4 (C-4), 70.4 (C-2), 68.7 (C-3), 66.9 
(RC=CHCH2CH2CH2), 62.6 (C-6), 33.6 (SCH2), 22.4 (RC=CHCH2CH2CH2), 22.4 
(C(O)CH3), 21.4 (C(O)CH3), 20.9 (C(O)CH3), 20.7 (C(O)CH3), 19.5 (RC=CHCH2CH2CH2); 
HRESIMS: Found [M+H]+ 461.1476 C20H29O10S requires 461.1481, [M+Na]+ 483.1295 
C20H29O10S requires 483.1301. 
 
3.4 (6S)-1,7-Dioxa-4-thia-(1,2-dideoxy-β-D-glucopyranoso)[1,2-b]-spiro[6.6]undecane 
(10) 
A solution of sodium methoxide (380 mg, 6.95 mmol) in anhydrous MeOH (10 mL) was 
added to a solution of 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranosyl-6-(1-
hydroxymethyl)-3,4-dihydro-2H-pyran (9) (4.0 g, 8.69 mmol) in anhydrous MeOH (100 mL) 
and stirred overnight.  The reaction mixture was then neutralised with Amberlite IRC H+ 
resin and concentrated to leave a crude oil.  The resulting oil was redissolved in chloroform 
(50 mL) and acidified with p-TSA (800 mg, 4.37 mmol) and left to stir for 45 min.  The 
reaction mixture was then neutralised with Et3N and concentrated to afford a crude oil.  The 
crude oil was purified by flash chromatography (silica gel; 9:1 (v/v) CH2Cl2-MeOH) to afford 
(6S)-1,7-dioxa-4-thia-(1,2-dideoxy-β-D-glucopyranoso)[1,2-b]-spiro[6.6]undecane (10) (1.5g, 
60%) as a colourless foam; RF  0.24 (9:1 (v/v) CH2Cl2-MeOH); [α]D21 +19.0 (c 2, CHCl3); 
FTIR (vmax/cm-1) 3391 (OH), 2941 (C-H); 1H NMR: δH (500 MHz, CDCl3); 4.39 (d, 1H, J1,2 
8.5 Hz, H-1), 3.93 (dd, 1H, J5,6 1 Hz, J6,6' 12.8 Hz, H-6), 3.81 (dd, 1H, J5,6' 1 Hz, J6,6' 12.8 Hz, 
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H-6'), 3.76 (m, 2H, H-a, H-a'), 3.74 (m, 1H, H-4), 3.69 (dd, 1H, J1,2 8.5 Hz, J2,3 9.4 Hz, H-2), 
3.59 (dd, 1H, J2,3 9.4 Hz, J3,4 9.4 Hz, H-3), 3.48 (m, 1H, H-5), 2.94 (d, 1H, JSCHeq,SCHax 13.6 
Hz, SCHeq), 2.67 (d, 1H, JSCHeq,SCHax 13.6 Hz, SCHax), 1.81 (m, 2H, H-b, H-b'), 1.65 (m, 2H, 
H-c, H-c'), 1.53 (m, 2H, H-d, H-d'); 13C NMR: δC (75 MHz, CDCl3); 98.6 (C-e), 80.6 (C-1), 
75.9 (C-5), 75.8 (C-4), 73.8 (C-2), 70.9 (C-3), 62.6 (C-6), 61.7 (C-a), 37.7 (SCH2), 34.6 (C-
d), 25.1 (C-b), 19.2 (C-c); HRESIMS: Found [M+Na]+ 315.0873 C12H20NaO6S requires 
315.0878. 
 
3.5 (6S)-1,7-Dioxa-(3,4,6-tri-O-acetyl-1,2-dideoxy-β-D-glucopyranoso)-4-thia-[1,2-b]-
spiro[6.6]undecane (11)  
Et3N (1.18 mL, 8.48 mmol), acetic anhydride (810 μL, 8.48 mmol) and DMAP (5 mg, 0.05 
mmol), were added to a solution of (6S)-1,7-dioxa-4-thia-(1,2-dideoxy-β-D-
glucopyranoso)[1,2-b]-spiro[6.6]undecane (10) (0.75 g, 2.57 mmol) in CH2Cl2 (50 mL).  The 
reaction mixture was left to stir for 1 h, before quenching with aq. NaHCO3 (25 mL).  The 
organic layer was separated, dried (MgSO4) and concentrated to leave a crude solid.  The 
crude solid was purified by flash column chromatography (silica gel; 1:1 (v/v) hexane-
EtOAc) to afford (6S)-1,7-dioxa-3,4,6-tri-O-acetyl-1,2-dideoxy-β-D-glucopyranoso)-4-thia-( 
[1,2-b]-spiro[6.6]undecane (11) (1.07g, 100%) as colourless plates mp: 159.0-160.3 °C (from 
methanol); RF 0.27 (2:1 (v/v) hexane-EtOAc); [α]D21 +16.9 (c 2.6, CHCl3); FTIR (vmax/cm-1) 
1747 (C=O), 2946 (C-H); 1H NMR: δH (400 MHz, CDCl3); 5.14 (dd, 1H, J2,3 9.3 Hz, J3,4 9.3 
Hz, H-3), 5.12 (dd, 1H, J3,4 9.3 Hz, J4,5 9.3 Hz, H-4), 4.40 (d, 1H, J1,2 9.3 Hz, H-1), 4.22 (dd, 
1H, J5,6 4.6, J6,6' 12.3 Hz, H-6), 4.13 (dd, 1H, J5,6' 2.3, J6,6' 12.3 Hz, H-6'), 3.91 (dd, 1H, J1,2 
9.3 Hz, J2,3 9.3 Hz, H-2), 3.75 (m, 1H, H-5), 3.65 (m, 2H, H-a, H-a'), 2.95 (d, 1H, JSCHeq,SCHax 
13.7 Hz, SCHeq), 2.66 (d, 1H, JSCHeq,SCHax 13.7 Hz, SCHax), 2.08 (s, 3H, C(O)CH3), 2.06 (s, 
3H, C(O)CH3), 2.03 (s, 3H, C(O)CH3), 1.56 (m, 6H, H-b, H-b', H-c, H-c', H-d, H-d'); 13C 
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NMR: δC (75 MHz, CDCl3); 171.2, 170.6, 169.9 (C(O)CH3), 93.1 (C-e), 77.2 (C-1), 76.2 (C-
5), 73.4 (C-4), 72.0 (C-2), 68.8 (C-3), 62.4 (C-6), 61.6 (C-a), 37.6 (SCH2), 34.5 (C-d), 25.1 
(C-b), 21.2 (C(O)CH3), 21.1 (C(O)CH3), 21.0 (C(O)CH3), 19.0 (C-c); HRESIMS: Found 
[M+Na]+ 441.1190 C18H26NaO9S requires 441.1195. 
 
3.6 (6S)-1,7-Dioxa-(3,4,6-tri-O-acetyl-1,2-dideoxy-β-D-glucopyranoso)-4-thia-[1,2-b]-
spiro[6.6]undecane (R/S)-S-oxide (13) 
A solution of m-CPBA (250 mg, 1.26 mmol) in CH2Cl2 (1 mL) was added to a solution of 
(6S)-1,7-dioxa-(3,4,6-tri-O-acetyl-1,2-dideoxy-β-D-glucopyranoso)-4-thia-([1,2-b]-
spiro[6.6]undecane (11) (500 mg, 1.20 mmol) in CH2Cl2 (12 mL) and stirred for ten min at 
−78°C.  The reaction mixture was then quenched with aq. NaHCO3 (25 mL) and diluted with 
CH2Cl2 (50 mL), and the organic phase was separated and concentrated to afford a crude 
syrup.  The crude syrup was then purified by flash column chromatography (silica gel; 98:2 
(v/v) CH2Cl2-MeOH) to afford (6S)-1,7-dioxa-(3,4,6-tri-O-acetyl-1,2-dideoxy-β-D-
glucopyranoso)-4-thia-[1,2-b]-spiro[6.6]undecane (R/S)-S-oxide (13) (480 g, 93%, d.r: 97:3) 
as an amorphous solid; RF 0.66 (9:1 (v/v) CH2Cl2-MeOH); [α]D21 +6.5 (c 0.4, CHCl3); (6S)-
1,7-dioxa-4-thia-(3,4,6-tri-O-acetyl-1,2-dideoxy-β-D-glucopyranoso)[1,2-b]-
spiro[6.6]undecane (R)-S-oxide (13-R): FTIR (vmax/cm-1) 1740 (C=O), 2940 (C-H); 1H 
NMR: δH (500 MHz, CDCl3); 5.23 (dd, 1H, J2,3 9.4 Hz, J3,4 9.4 Hz, H-3), 5.14 (dd, 1H, J3,4 
9.4 Hz, J4,5 9.4 Hz, H-4), 4.35 (dd, 1H, J5,6 4.4, J6,6' 12.6 Hz, H-6), 4.22 (d, 1H, J1,2 10.2 Hz, 
H-1), 4.19 (dd, 1H, J5,6' 2.4, J6,6' 12.6 Hz, H-6'), 3.81 (m, 1H, H-5), 3.72 (dd, 1H, J1,2 10.2 Hz, 
J2,3 9.4 Hz, H-2), 3.68-3.65 (m, 1H, H-a), 3.54 (d, 1H, JSCHeq,SCHax 12.6 Hz, SCHeq), 3.50-
3.46 (m, 1H, H-a'), 2.77 (d, 1H, JSCHeq,SCHax 12.6 Hz, SCHax), 2.08 (s, 3H, C(O)CH3), 2.06 (s, 
3H, C(O)CH3), 2.05 (s, 3H, C(O)CH3), 1.58 (m, 6H, H-b, H-b', H-c, H-c', H-d, H-d'); 13C 
NMR: δC (75 MHz, CDCl3); 171.2, 170.7, 169.9 (C(O)CH3), 98.6 (C-e), 95.9 (C-1), 77.4 (C-
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3), 73.3 (C-5), 67.9 (C-4), 67.5 (C-2), 61.9 (C-6), 60.2 (SCH2), 33.9 (C-b), 24.5 (C-d), 24.5 
(C(O)CH3), 21.1 (C(O)CH3), 21.1 (C(O)CH3), 18.7 (C-c), 60.2 (C-a); ); HRESIMS: Found 
[M+Na]+ 457.1139 C18H26NaO10S requires 457.1144; (6S)-1,7-dioxa-(3,4,6-tri-O-acetyl-1,2-
dideoxy-β-D-glucopyranoso)-4-thia-[1,2-b]-spiro[6.6]undecane (S)-S-oxide (13-S): mp: 
194.0-196.1°C (from hexane-EtOAc): 1H NMR: δH (500 MHz, CDCl3); 5.36 (dd, 1H, J2,3 9.6 
Hz, J3,4 9.6 Hz, H-3), 5.16 (dd, 1H, J3,4 9.0 Hz, J4,5 9.0 Hz, H-4), 4.27 (dd, 1H, J5,6 6.4, J6,6' 
13.7 Hz, H-6), 4.09 (d, 1H, J1,2 9.9 Hz, H-1), 4.27 (dd, 1H, J5,6' 6.4, J6,6' 13.7 Hz, H-6'), 3.89 
(m, 1H, H-5), 4.72 (dd, 1H, J1,2 9.9 Hz, J2,3 9.6 Hz, H-2), 3.68-3.65 (m, 1H, H-a), 3.50-3.46 
(m, 1H, H-a'), 3.26 (d, 1H, JSCHeq,SCHax 14.9 Hz, SCHeq), 2.44 (d, 1H, JSCHeq,SCHax 14.9 Hz, 
SCHax), 2.08 (s, 3H, C(O)CH3), 2.06 (s, 3H, C(O)CH3), 2.05 (s, 3H, C(O)CH3), 1.80 (m, 6H, 
H-b, H-b', H-c, H-c', H-d, H-d'). 
 
3.7 (6S)-1,7-Dioxa-(3,4,6-tri-O-benzyl-1,2-dideoxy-β-D-glucopyranoso)-4-thia-[1,2-b]-
spiro[6.6]undecane (R)-S-oxide (14-R) 
NaH (60% dispersion in oil, 107 mg, 4.45 mmol) was added in portions to a stirred solution 
of (6S)-1,7-dioxa-(1,2-dideoxy-β-D-glucopyranoso)-4-thia-[1,2-b]-spiro[6.6]undecane (10) 
(420 mg, 1.48 mmol) in N,N-dimethylformamide (10 mL) at 0°C, and stirred for 30 min 
while H2(g) evolved.  Benzyl bromide (616 μL, 5.18 mmol) was then added dropwise at 0 °C, 
and the reaction mixture stirred for a further 3 h. The reaction mixture was quenched with 
MeOH (10 mL) and concentrated.  The crude solid was then redissolved in CH2Cl2 (20 mL) 
and washed with aq. NaCl (2 x 20 mL), dried (MgSO4) and concentrated to leave a crude 
benzylated spiroketal 12.  The crude benzylated spiroketal 12 was redissolved in CH2Cl2 (5 
mL) and cooled to −78 °C, and a solution of m-CPBA (350 mg, 1.73 mmol) in CH2Cl2 (5 
mL) was slowly added over 5 min.  The reaction mixture was stirred for 30 min at −78 °C 
and then quenched with aq. NaHCO3 (10 mL) and diluted with CH2Cl2 (10 mL).  The organic 
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phase was then separated, washed with aq. NaCl (2 x 10 mL), dried (MgSO4) and 
concentrated to leave a crude colourless solid. The crude solid was purified by flash column 
chromatography (silica; 1:1 (v/v) hexane-EtOAc) to afford (6S)-1,7-dioxa-(3,4,6-tri-O-
benzyl-1,2-dideoxy-β-D-glucopyranoso)-4-thia-[1,2-b]-spiro[6.6]undecane (R)-S-oxide (14-
R) (243 mg, 30%, dr: 99:1) as a colourless syrup; RF 0.19 (1:1 (v/v) EtOAc-hexane); [α]D21 
+1.3 (c 1.5, CHCl3); FTIR (vmax/cm-1) 2944 (C-H), 1099, 1051 (S=O); 1H NMR: δH (500 
MHz, CDCl3); 7.35-7.14 (m, 15H, ArH), 5.02 (d, 1H, J 10.3 Hz, OCH2Ph), 4.82 (d, 2H, J 
10.3 Hz, J 10.3 Hz, OCH2Ph), 4.66 (d, 1H, J 12.0 Hz, OCH2Ph), 4.58 (d, 1H, J 10.3 Hz, 
OCH2Ph), 4.52 (d, 1H, J 12.0 Hz, OCH2Ph), 4.11 (d, 1H, J1,2 9.4 Hz, H-1), 3.87-3.83 (m, 3H, 
H-3, H-a, H-a'), 3.78-3.71 (m, 2H, H-5, H-6), 3.66 (dd, 1H, J1,2 9.4 Hz, J2,3 9.4 Hz, H-2), 3.60 
(dd, 1H, J5,6' 5.1 Hz, J6,6' 11.1 Hz, H-6'), 3.57-3.53 (m, 2H, H-4, SCHeq), 2.75 (d, 1H, 
JSCHeq,SCHax 12.0 Hz, SCHax), 1.83-1.76 (m, 2H, H-d, H-c), 1.68-1.58 (m, 3H, H-b, H-c', H-d'), 
1.47 (d, 1H, J 12.8 Hz, H-b'); 13C NMR: δC (75 MHz, CDCl3); 138.2, 137.9, 128.5, 128.4, 
128.4, 128.0, 127.9, 127.8, 127.7 (ArC), 98.1 (C-e), 95.8 (C-1), 83.6 (C-2), 80.3 (C-4), 76.6 
(C-3), 75.8, 75.5, 73.7 (OCH2Ph), 70.3 (C-5), 67.9 (C-a), 60.9 (C-6), 59.6 (SCH2), 33.8 (C-
d), 24.0 (C-b), 18.4 (C-c); HRESIMS: Found [M+Na]+ 601.2238, C33H38O7SNa requires 
601.2230. 
 
3.8 General procedure for glycosylation reactions with oxathiane spiroketal-S-oxides 
Tf2O (1.1 equiv.) was added to a solution of oxathiane spiroketal-S-oxide 13-R or 14-R (1 
equiv.), 1,3,5-trimethoxybenzene (1.1 equiv.) or 1,3-dimethoxybenzene (1.1 equiv.), DIPEA 
(1.2 equiv.) and 4 Å molecular sieves in CH2Cl2 or C2H4Cl2 (initial donor concentration 0.26 
M), cooled to −30 ºC.  The reaction mixture was warmed to room temperature over 10 min 
and then DIPEA (1.3 equiv.), followed by a solution of the glycosyl acceptor (1.5 equiv.) in 
CH2Cl2 or C2H4Cl2 (final donor concentration 0.11 M) was added and the reaction mixture 
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was stirred for 24 h at 37 °C or 50 °C (when using donor 13-R), or room temperature (when 
using donor 14-R).  The reaction mixture was then diluted with CH2Cl2 (5 mL), washed with 
1M HCl (2 x 5 mL), aq. NaHCO3 (2 x 5 mL) and aq. NaCl (2 x 5 mL), dried (MgSO4) and 
concentrated to afford the crude product.  The crude product was then redissolved in CH2Cl2 
(1 mL) and cat. BF3·OEt2 and MeOH (1.5 equiv.) were added, after stirring for 30 min at 
room temperature the reaction mixture was diluted with CH2Cl2 (5 mL) washed with aq. 
NaCl (5 mL), dried (MgSO4) and concentrated to afford the crude O-2 unprotected glycoside.  
The crude glycoside was purified by size exclusion chormatography (Sephadex LH-20 resin; 
eluted with MeOH (50 mL/h)) to afford the desired O-2 unprotected glycoside.  
 
3.8.1 From 2,4,6-trimethoxyphenyl (TMP) oxathiane spiroketal sulfonium ions (21): 
3,4,6-Tri-O-acetyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (20)19  
24 h at 50 °C = 3,4,6-tri-O-acetyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-
D-galactopyranose (20) as a colourless oil (49 mg, 38%, α:β 93:7); RF 0.25 (1:1 (v/v) hexane-
EtOAc).  Analytical data was identical to that reported previously. 
24 h at 37 °C = 3,4,6-tri-O-acetyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-
D-galactopyranose (20) as a colourless oil (18 mg, 60%, α:β 93:7) (Table 1, entry 1).  
Analytical data was identical to that reported previously. 
 
3.8.2 Isopropyl 3,4,6-tri-O-acetyl-α-D-glucopyranoside (28) (Table 1, entry 2) 
Isopropyl 3,4,6-tri-O-acetyl-α-D-glucopyranoside (28) as a colourless syrup (22 mg, 61%, α:β 
98:2); RF 0.38 (1:1 (v/v) hexane-EtOAc); [α]D21 −56 (c 0.2, CHCl3); FTIR (vmax/cm-1): 1738 
(C=O); 1H NMR: δH (500 MHz, CDCl3); 5.21 (dd, 1H, J2,3 9.7 Hz, J3,4 9.7 Hz, H-3), 5.01 (d, 
1H, J1,2 3.8 Hz, H-1), 5.00 (dd, 1H, J4,5 9.9 Hz, J3,4 9.7 Hz, H-4), 4.26 (dd, 1H, J6,6' 12.4 Hz, 
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J5,6 4.9 Hz, H-6), 4.09 (dd, 1H, J6,6' 12.4 Hz, J5,6' 2.0 Hz, H-6'), 4.05-4.03 (m, 2H, H-5, 
CH(CH3)2), 3.65 (ddd, 1H, J1,2 3.8 Hz, J2,3 9.7 Hz, J2,OH-2 11.5 Hz, H-2), 2.08 (s, 3H, 
C(O)CH3), 2.03 (s, 3H, C(O)CH3), 2.03 (s, 3H, C(O)CH3), 1.96 (d, 1H, J2,2-OH 11.5 Hz, 2-
OH), 1.22 (s, 3H, CH3), 1.20 (s, 3H, CH3); 13C NMR: δC (75 MHz, CDCl3); 170.0 
(C(O)CH3), 97.3 (C-1), 74.0, 72.1, 71.1, 68.5 (C-2, C-3, C-4, C-5), 62.5 (C-6), 30.1 
(CH(CH3)2), 23.6, 22.3 (CH3); HRESIMS: Found [M+Na]+ 371.1323, C15H24O9Na requires 
373.1313. 
 
3.8.3 3,4,6-Tri-O-benzyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (27)19(Table 1, entry 3) 
3,4,6-Tri-O-benzyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (27) as a colourless syrup (28 mg, 58%, α:β 92:8); RF 0.77 (1:1 (v/v) hexane-
EtOAc).  Analytical data was identical to that reported previously. 
 
3.8.4 Isopropyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside (29)19 (Table 1, entry 4) 
Isopropyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside (29) as a colourless oil (27 mg, 57%, α:β 
94:6); RF 0.70 (1:1 (v/v) hexane-EtOAc).  Analytical data was identical to that reported 
previously. 
 
3.8.5 From 2,4-dimethoxyphenyl (DMP) oxathiane spiroketal sulfonium ion (28): 
3,4,6-Tri-O-acetyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (20)19 (Table 1, entry 5) 
3,4,6-Tri-O-acetyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (20) as a colourless oil (19 mg, 50%, α:β 86:14).  Analytical data was 
identical to that reported previously. 
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3.8.6 Isopropyl 3,4,6-tri-O-acetyl-α-D-glucopyranoside (28) (Table 1, entry 6) 
Isopropyl 3,4,6-tri-O-acetyl-α-D-glucopyranoside (28) as a colourless syrup (13 mg, 52%, α:β 
95:5).  For analytical data see 3.8.2. 
 
3.9 3,4,6-Tri-O-acetyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (20)19 (Table 1, entry 9) 
Tf2O (20 µL, 0.117 mmol) was added to a solution of 2-methoxy-2-(S)-phenyl-(3,4,6-tri-O-
acetyl-1,2-dideoxy-β-D-glucopyranoso)[1,2-e]-1,4-oxathiane (R)-S-oxide (25-R) (50 mg, 
0.106 mmol), DTBMP (87 mg, 0.425 mmol), 1,3-dimethoxybenzene (15 μL, 0.117 mmol) 
and 4 Å molecular sieves (50 mg) in C2H4Cl2 (400 µL) at −30 °C.  The reaction mixture was 
warmed to −10 °C over 10 min, then a solution of 1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (19) (69 mg, 0.265 mmol) in C2H4Cl2 (100 µL) was added.  The reaction 
mixture was then heated at 50 ºC for 2 h, allowed to cool and diluted with CH2Cl2 (10 mL), 
washed with 1M HCl (3 x 10 mL), aq. NaHCO3 (2 x 10 mL) and aq. NaCl (2 x 10 mL) and 
concentrated to afford a  crude oil. The crude oil was dissolved in DCM (1 mL), cat. 
BF3·OEt2 and MeOH (0.163 mmol) was added, after stirring for 30 min at room temperature. 
the reaction mixture was diluted with CH2Cl2 (5 mL) washed with aq. NaCl (5 mL), dried 
(MgSO4) and concentrated to afford a crude yellow oil. The crude oil was purified by size 
exclusion chormatography (Sephadex LH-20 resin; eluted with MeOH (50 mL/h)) to afford 
3,4,6-tri-O-acetyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (20) as a colourless oil (36 mg, 62%, α:β > 98:2).  Analytical data was 
identical to that reported previously. 
 
3.10 X-ray crystallography 
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CCDC ID: 805132 contains the supplementary crystallographic data for this paper. Copies of 
this information may be obtained free of charge from the Cambridge Crystallographic Data 
Centre, 12 Union Road, Cambridge, CB2 1EZ, UK. (fax: +44-1223-336033, or via: 
http://www.ccdc.cam.ac.uk/products/csd/request/). 
Measurements were carried out at 150 K on a Bruker-Nonius Apex X8 diffractometer 
equipped with an Apex II CCD detector and using graphite monochromated Mo-Kα radiation 
from a FR591 rotating anode generator. The structure was solved by direct methods and 
refined using SHELXL-97. Compound 13-S crystallises in the chiral space group C2. All 
non-hydrogen atoms were refined anisotropically. Most hydrogen atoms could be located in a 
difference Fourier map but, following refinement, their positions were unstable. In the final 
stages of the refinement, they were placed in calculated positions and refined using a riding 
model.  C-H distances: CH3, 0.98 Å; CH2, 0.99 Å; CH, 1.00 Å. All Uiso(H) values were 
constrained to be 1.2 times (1.5 for methyl) Ueq of the parent atom. Anomalous dispersion 
effects were sufficient to determine the absolute configuration since the Flack parameter 
refined to 0.07(14). There is a high positive residual density of 1.45 e Å-3 at a distance of 1.28 
Å from S1. This is in the approximate position of the S1 lone pair. If this peak is modelled as 
an oxygen atom then the S1-O distance is 1.333 Å and the oxygen atom has an ellipsoid with 
an unreasonably large axis. The electron density associated with O1 is 5.15 e Å-3 and the S1-
O distance is 1.436 Å. Thus, the sulfoxide 13-S was considered to be the most reasonable 
model.  
Supplementary Information 
Supplementary data associated with this article can be found, in the online version, at doi: 
xxxx. 
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